Kenvue Inc.
Industry
- Pharmaceuticals
- OTC, Consumer
Latest on Kenvue Inc.
Private investment in public equity (PIPE) transactions continue to be an important means of fundraising for publicly traded biopharmaceutical companies while the financial markets continue to recover
Use of Kenvue Inc. ’s Nicorette QuickMist nicotine replacement therapy (NRT) device provides “statistically significant and fast relief” of urges to vape, according to a recently published study fund
Losing consumer health product market share to private label isn’t appearing on Kenvue Inc. ’s radar even though market analysts say consumers are “being squeezed” and Kenvue and its competitors shou
Kenvue Inc. chief growth officer Charmaine England, in her first chance to present the firm’s growth strategy to investors, adds her insight to management’s message that Kenvue isn’t the Johnson & J